A framework for evaluating the costs of malaria elimination interventions: An application to reactive case detection in Southern Province of Zambia, 2014

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Larson, Bruce A ^a   Ngoma, Thandiwe ^b   Silumbe, Kafula ^b   Rutagwera, Marie Reine I ^b   Hamainza, Busiku ^c   Winters, Anna M ^d,e   Miller, John M ^b   Scott, Callie A ^f  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b Chainama Hospital College Grounds   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

^d School of Public and Community Health Sciences ^*  (Zambia)

^e UNIVERSITY OF MONTANA   (United States)

^f PATH   (United States)

Author keywords

Community case management; Cost; Elimination; Malaria; Reactive case detection; Zambia

Indexed keywords

ACCESS TO INFORMATION; AFRICA SOUTH OF THE SAHARA; ARTICLE; CATCHMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC TEST; DISEASE ELIMINATION; ECONOMIC EVALUATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; PUBLIC HEALTH; ZAMBIA; COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; ECONOMICS; PROCEDURES;

COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; HEALTH CARE COSTS; HUMANS; MALARIA; ZAMBIA;

EID: 84981523351     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1457-5     Document Type: Article

References (37)

1. Marsh K. Research priorities for malaria elimination. Lancet. 2010;376:1626-7.
2. Feachem RGA, Phillips AA, Targett GA, Snow RW. Call to action: priorities for malaria elimination. Lancet. 2010;376:1517-21.
3. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda to underpin malaria eradication. PLoS Med. 2011;8:e1000406.
4. Eisele TP, Larsen D, Steketee RW. Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Int J Epidemiol. 2010;39(Suppl 1):i88-101.
5. Tables of costs and prices used in WHO-CHOICE analysis. http://www.who.int/choice/costs/en/. Accessed 19 Jul 2016.
6. White MT, Conteh L, Cibulskis R, Ghani AC. Costs and cost-effectiveness of malaria control interventions - a systematic review. Malar J. 2011;10:337.
7. Boardman AE, Greenberg DH, Vining AR, Weimer DL. Cost-benefit analysis: concepts and practice. 3rd ed. Upper Saddle River: Prentice Hall; 2006.
8. Drummond MF, Sculper MJ, Torrnace GW, O'Brien BJ, Stoddart GL. Methods for the Economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
9. Harberger AC, Jenkins GP. Cost-benefit analysis. Cheltenham: Edward Elgar; 2002.
10. Walker D. Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan. 2001;16:113-21.
11. Phillips M, Mills A, Dye C. Guidelines for cost-effectiveness analysis of vector control. Geneva: World Health Organization; 1993.
12. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ. 2013;346:f1049.
13. Sun DW, Du JW, Wang GZ, Li YC, He CH, Xue RD, et al. A cost-effectiveness analysis of Plasmodium falciparum malaria elimination in Hainan Province, 2002-2012. Am J Trop Med Hyg. 2015;93:1240-8.
14. Yukich J, Lengeler C, Tediosi F, Brown N, Mulligan J, Chavasse D, et al. Costs and consequences of large-scale vector control for malaria. Malar J. 2008;7:258.
15. Faraj C, Yukich J, el Adlaoui B, Wahabi R, Mnzava AP, Kaddaf M, et al. Effectiveness and cost of insecticide-treated bed nets and indoor residual spraying for the control of cutaneous leishmaniasis: a cluster-randomized control trial in Morocco. Am J Trop Med Hyg. 2016;94:679-85.
16. UNAIDS. Costing guidelines for HIV prevention strategies. Geneva: Joint United Nations Programme on HIV/AIDS; 2000.
17. Walker D, Kumaranayake L. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy Plan. 2002;17:112-8.
18. Scott CA, Iyer HS, Lembela Bwalya D, Bweupe M, Rosen SB, Scott N, et al. Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia. PLoS One. 2013;8:e72444.
19. Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, et al. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013;8:e67910.
20. Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, et al. Resource utilization and costs of care prior to ART initiation for pediatric patients in Zambia. AIDS Res Treat. 2014;2014:5.
21. Zurovac D, Larson BA, Sudoi RK, Snow RW. Costs and cost-effectiveness of a mobile phone text-message reminder programmes to improve health workers' adherence to malaria guidelines in Kenya. PLoS One. 2012;7:e52045.
22. Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am J Trop Med Hyg. 2008;78:884-91.
23. Larson BA, Amin AA, Noor AM, Zurovac D, Snow RW. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets. BMC Public Health. 2006;6:314.
24. Zurovac D, Larson BA, Akhwale W, Snow RW. The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya. Trop Med Int Health. 2006;11:1185-94.
25. Larson B, Schnippel K, Ndibongo B, Long L, Fox MP, Rosen S. How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima™ analyzer in South Africa. PLoS One. 2012;7:e35444.
26. Larson B, Wambua N. How to calculate the annual costs of NGO-implemented programmes to support orphans and vulnerable children: a six-step approach. J Int AIDS Soc. 2011;14:59.
27. Larson BA. Costs, outcomes, and cost-effectiveness of OVC interventions. Boston: OVC-Care Project Report, Boston University Center for Global Health and Development; 2010.
28. Larson BA, Avaliani S, Golub A, Rosen S, Shaposhnikov S. The economics of air pollution health risks in Russia: a case study of Volgograd. World Dev. 1999;27:1803-19.
29. Mulligan JA, Yukich J, Hanson K. Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets. Malar J. 2008;7:32.
30. Yukich J, D'Acremont V, Kahama J, Swai N, Lengeler C. Cost savings with rapid diagnostic tests for malaria in low-transmission areas: evidence from Dar es Salaam, Tanzania. Am J Trop Med Hyg. 2010;83:61-8.
31. Yukich JO, Lengeler C, Tediosi F, Brown N, Mulligan JA, Chavasse D, et al. Costs and consequences of large-scale vector control for malaria. Malar J. 2008;7:258.
32. Yukich JO, Zerom M, Ghebremeskel T, Tediosi F, Lengeler C. Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets. Malar J. 2009;8:51.
33. Larsen DA, Chisha Z, Winters B, Mwanza M, Kamuliwo M, Mbwili C, et al. Malaria surveillance in low-transmission areas of Zambia using reactive case detection. Malar J. 2015;14:465.
34. DHIS2. https://www.dhis2.org/. Accessed 19 Jul 2016.
35. The World economic outlook databases. http://www.imf.org/external/ns/cs.aspx?id=28. Accessed 14 Aug 2015.
36. Bank of Zambia. http://www.boz.zm/. Accessed 12 Jan 2015.
37. Worrall E, Fillinger U. Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis. Malar J. 2011;10:338.